MAP also provided recommendations for removal of measures currently in these federal programs.
MAP posted its draft report with a two-week comment period on Jan. 13, and received comments on the draft from organizations, such as the American Hospital Association, America’s Health Insurance Plans, PhRMA, AdvaMed, and other trade associations and industry groups. Several professional societies commented in opposition to MAP’s recommendation to remove measures from PQRS, noting that these measures continue to fill important gap areas. Several organizations commented against recommendations to continue including stroke outcomes measures in the IQR Program due to scientific issues with the measures. In addition, commenters opposed MAP’s conditional support for the adoption of an all-cause readmissions measure in the Hospital Readmissions Reduction Program, noting that the measure is not yet ready for implementation. Due to an aggressive timeline, MAP did not make any changes to its recommendations based on public comment.
This is the third year MAP provided similar input to HHS, and HHS has increasingly placed significant weight on MAP recommendations. Their recommendations in the final pre-rulemaking report are likely to impact federal rulemaking later this year, as well as in subsequent years. Gap areas identified by MAP will likely impact the national measure development and endorsement agenda. Although MAP did not make any changes to the report, HHS may consider stakeholder comments that highlight discrepancies on the inclusion or removal of specific measures.
MAP will provide input on measures for federal programs again next year, and will provide input to HHS as requested on an ad hoc basis throughout 2014. MAP also released a report for public comment which provides input on measures for the Medicaid/Medicare dual eligible population on Feb. 5, and will release a final report in the coming months. MAP will also convene a Medicaid Task Force to provide guidance to HHS on updates to the Core Set of Measures for Medicaid-Eligible Adults later this year.
To read MAP’s Final Pre-Rulemaking Report, click here.